121 related articles for article (PubMed ID: 2404576)
21. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H
Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202
[TBL] [Abstract][Full Text] [Related]
22. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
23. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
[TBL] [Abstract][Full Text] [Related]
24. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor.
Eder IE; Hoffmann J; Rogatsch H; Schäfer G; Zopf D; Bartsch G; Klocker H
Cancer Gene Ther; 2002 Feb; 9(2):117-25. PubMed ID: 11857028
[TBL] [Abstract][Full Text] [Related]
26. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
[TBL] [Abstract][Full Text] [Related]
27. Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy.
Van der Kwast TH; Têtu B; Fradet Y; Dupont A; Gomez J; Cusan L; Diamond P; Labrie F
Prostate; 1996 Apr; 28(4):227-31. PubMed ID: 8602398
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line.
Wang LG; Ossowski L; Ferrari AC
Oncogene; 2004 Jul; 23(30):5175-84. PubMed ID: 15156193
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.
Collett GP; Betts AM; Johnson MI; Pulimood AB; Cook S; Neal DE; Robson CN
Clin Cancer Res; 2000 Aug; 6(8):3241-8. PubMed ID: 10955810
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor and invasion in prostate cancer.
Hara T; Miyazaki H; Lee A; Tran CP; Reiter RE
Cancer Res; 2008 Feb; 68(4):1128-35. PubMed ID: 18281488
[TBL] [Abstract][Full Text] [Related]
31. Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT.
Isaacs JT; Heston WD; Weissman RM; Coffey DS
Cancer Res; 1978 Nov; 38(11 Pt 2):4353-9. PubMed ID: 698976
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor as a potential sign of prostate cancer metastasis.
Lévesque MH; El-Alfy M; Cusan L; Labrie F
Prostate; 2009 Nov; 69(15):1704-11. PubMed ID: 19670238
[TBL] [Abstract][Full Text] [Related]
33. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
34. BRCA1, BRCA2, AR and IGF-I expression in prostate cancer: correlation between RT-qPCR and immunohistochemical detection.
Rabiau N; Déchelotte P; Adjakly M; Kemeny JL; Guy L; Boiteux JP; Kwiatkowski F; Bignon YJ; Bernard-Gallon D
Oncol Rep; 2011 Sep; 26(3):695-702. PubMed ID: 21667031
[TBL] [Abstract][Full Text] [Related]
35. Steroid hormone receptor characterization of several histologic variants of a rat prostatic adenocarcinoma.
Markland FS; Chopp RT; Cosgrove MD; Howard EB
J Supramol Struct; 1978; 9(4):509-24. PubMed ID: 750763
[TBL] [Abstract][Full Text] [Related]
36. Effects of neonatal estrogen exposure on prostatic secretory genes and their correlation with androgen receptor expression in the separate prostate lobes of the adult rat.
Prins GS; Woodham C; Lepinske M; Birch L
Endocrinology; 1993 Jun; 132(6):2387-98. PubMed ID: 8504743
[TBL] [Abstract][Full Text] [Related]
37. Murine monoclonal antibodies reactive with a variety of androgen independent Dunning rat prostate adenocarcinoma sublines also reactive with human prostate adenocarcinoma.
Tjota A; Lee MT; Isaacs JT; Kadohama N; Lee CL
J Urol; 1991 Jul; 146(1):205-12. PubMed ID: 2056591
[TBL] [Abstract][Full Text] [Related]
38. Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma system.
Cooke DB; Quarmby VE; Petrusz P; Mickey DD; Der CJ; Isaacs JT; French FS
Prostate; 1988; 13(4):273-87. PubMed ID: 3064050
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic significance of cell proliferation, microvascular density and androgen receptor level in prostatic adenocarcinoma].
Lefterov SI; Gorelov SI; Krivolapov IuA
Vopr Onkol; 2009; 55(6):740-5. PubMed ID: 20210018
[TBL] [Abstract][Full Text] [Related]
40. Intermediate filament expression and the progression of prostatic cancer as studied in the Dunning R-3327 rat prostatic carcinoma system.
Ramaekers FC; Verhagen AP; Isaacs JT; Feitz WF; Moesker O; Schaart G; Schalken JA; Vooijs GP
Prostate; 1989; 14(4):323-39. PubMed ID: 2664736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
